Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries.
Carlos ChiattoneGuillermo José Ruiz ArgüellesCarolina PavlovskyElena J Tuna-AguilarAna L BasquieraLuis PalmerDanielle Leao Cordeiro de FariasSergio Schusterschitz da Silva AraujoKenny Mauricio Galvez-CardenasAlvaro Gomez DiazJennifer H LinYen-Wen ChenGerardo MachnickiMichelle MahlerLori ParisiPaula BarreyroPublished in: Hematology (Amsterdam, Netherlands) (2021)
Chlorambucil-based therapy, which has limited benefits, is frequently prescribed in Latin America. Prescribing novel agents for fludarabine-based therapy-ineligible patients with CLL is the need of the hour. Trial registration: ClinicalTrials.gov identifier: NCT02559583.